The company reported quarterly earnings of $146.1 million, or $1.43 per share, a sharp increase from the $120.9 million recorded in the prior-year period. This result comfortably exceeded the $130.5 million profit target anticipated by analysts polled by FactSet. Revenue for the quarter hit $1.54 billion, aligning with market projections and marking an improvement over the $1.41 billion reported a year ago.

On an adjusted basis, Encompass Health earned $1.46 per share, surpassing the $1.30 per share consensus forecast. Following the announcement, the company's stock rose to $110.98 as investors reacted to the double-digit growth in profitability.

Operational Strength and Patient Volume

Operational metrics showed broad improvement across the company’s facilities. Net patient revenue per discharge rose 4.1% to $22,273, while same-store discharge growth climbed 3.2% to reach 67,238. These gains suggest that Encompass is successfully managing pricing power alongside increased demand for its specialized medical services.

Looking toward the long term, the company issued revenue guidance for 2026 between $6.37 billion and $6.47 billion. This outlook places the company’s trajectory in line with the $6.44 billion currently estimated by analysts, signaling a stable growth path for the coming years.